Back to search

Article

In silico prediction of ARB resistance: A first step in creating personalized ARB therapy

2020-02-12

Abstract excerpt

Angiotensin II type 1 receptor (AT 1 R) blockers (ARBs) are among the most prescribed drugs. However, ARB effectiveness varies widely, and some patients do not respond to ARB therapy. One reason for the variability between patients is non-synonymous single nucleotide polymorphisms (nsSNPs) within agtr1 , the AT 1 R gene. There are over 100 nsSNPs in the AT 1 R; therefore, this study embarked on determining whi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2b847811-a7ee-5ebd-ab5f-c7ba439d5bf3
DOI
10.1101/2020.02.12.945402
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In silico prediction of ARB resistance: A first step in creating personalized ARB therapyDOI 10.1101/2020.02.12.945402
Select a neighboring publication to make it the new centre.